Pancreatic Ductal Adenocarcinoma Completed Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0034446 (Pancreatic Ductal Adenocarcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02981342A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal AdenocarcinomaTreatment